Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Correlation Between Blood Concentration of Sintilimab and Related Predictors with Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer

NCT06702683 is registered in ClinicalTrials.gov with Lin Liu as lead sponsor.

NCT NCT06702683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06702683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Correlation Between Blood Concentration of Sintilimab and Related Predictors with Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
Lead sponsor
Lin Liu
Phase
Observational
Overall status
Recruiting
Start date
February 17, 2023
Completion date
December 31, 2025
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric (cardia, body) cancer, gastric cancer adenocarcinoma metastatic, gastric carcinoma, gastric neoplasm